Loading…
Reported covered position: Special Asst to the President, White House (2008-2009); Dep Asst to the Vice President (2007-2008); Comms Dir, House Judiciary Cmte (2001-2007); Comms Dir, House Science Cmte (1999-2001); Press Sec, Rep. Porter Goss (1997-1998)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MICRO MEDICAL SOLUTIONS via INVARIANT LLC
2026 · third_quarter · Q3
Educate policymakers about new technologies for treating patients with advanced vascular disease.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
INFINITA CITY INC. via INVARIANT LLC
2026 · third_quarter · Q3
Source: Senate LDA
| 2 |
| 2026 |
| GLYTEC, LLC | 2 | 2026 |
| ZOCDOC | 2 | 2026 |
| KERECIS | 1 | 2026 |
| MICRO MEDICAL SOLUTIONS | 1 | 2026 |
Monitor issues related to vision care plans, including H.R.1521 - DOC Access Act of 2025, and S.1716 - Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Monitor issues related to vision care plans, including H.R.1521 - DOC Access Act of 2025, and S.1716 - Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Monitor policy issues related to high-fidelity Real-World Evidence to accelerate drug development.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SAGE via INVARIANT LLC
2026 · third_quarter · Q3
Monitor policies to support innovation in the senior living and long-term care sector. Monitor issues related to the use of artificial intelligence in health care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABRIDGE AI INC. via INVARIANT LLC
2026 · third_quarter · Q3
Promote policies that enhance the role of AI-enabled clinical documentation technology in health care delivery.
Educate staff on the capabilities of AI-enabled scribe technology in health care settings.
Educate policymakers on the role of AI-enabled clinical documentation technology in health care delivery and in reducing clinician burnout.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
BAXTER HEALTHCARE CORPORATION via INVARIANT LLC
2026 · third_quarter · Q3
Monitor issues affecting the medical device industry, including issues related to the supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DSM-FIRMENICH via INVARIANT LLC
2026 · third_quarter · Q3
Educate policymakers on the importance of biomanufacturing and protecting the domestic manufacturing capacity of vitamins.
Educate policymakers on the importance of UV filters in sunscreen and on issues related to women's health, maternal health, and infant formula supply.
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
VSP via INVARIANT LLC
2026 · third_quarter · Q3
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZOCDOC via INVARIANT LLC
2026 · third_quarter · Q3
Educate Members of Congress and the Administration about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to the Anti-Kickback Statute; discuss issues related to ghost networks; discuss issues related to the health care workforce; monitor issues related to the VA community care network.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CIGNA CORPORATION via INVARIANT LLC
2026 · third_quarter · Q3
Educate lawmakers on issues related to pharmacy benefit managers and drug pricing; proposals impacting employer-sponsored insurance.
Monitor pharmacy issues related to TRICARE.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAGE via INVARIANT LLC
2026 · second_quarter · Q2
Monitor policies to support innovation in the senior living and long-term care sector. Monitor issues related to the use of artificial intelligence in health care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZOCDOC via INVARIANT LLC
2026 · second_quarter · Q2
Educate Members of Congress and the Administration about the potential to use technology to improve access to care, reduce wait time, and improve patient engagement; discuss issues related to the Anti-Kickback Statute; discuss issues related to ghost networks; discuss issues related to the health care workforce; monitor issues related to the VA community care network.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INFINITA CITY INC. via INVARIANT LLC
2026 · second_quarter · Q2
Monitor policy issues related to high-fidelity Real-World Evidence to accelerate drug development.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BAXTER HEALTHCARE CORPORATION via INVARIANT LLC
2026 · second_quarter · Q2
Monitor issues affecting the medical device industry, including issues related to the supply chain.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VSP via INVARIANT LLC
2026 · second_quarter · Q2
Monitor issues related to vision care plans, including H.R.1521 - DOC Access Act of 2025, and S.1716 - Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION via INVARIANT LLC
2026 · second_quarter · Q2
Monitor pharmacy issues related to TRICARE.
Educate lawmakers on issues related to pharmacy benefit managers and drug pricing; proposals impacting employer-sponsored insurance; and proposals related to telehealth.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABRIDGE AI INC. via INVARIANT LLC
2026 · second_quarter · Q2
Promote policies that enhance the role of AI-enabled clinical documentation technology in health care delivery.
Educate policymakers on the role of AI-enabled clinical documentation technology in health care delivery and in reducing clinician burnout.
Educate staff on the capabilities of AI-enabled scribe technology in health care settings.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
2026 · second_quarter · Q2
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE, Veterans Affairs, Dept of (VA)
DSM-FIRMENICH via INVARIANT LLC
2026 · second_quarter · Q2
Educate policymakers on the importance of biomanufacturing and protecting the domestic manufacturing capacity of vitamins.
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
KERECIS via INVARIANT LLC
2026 · first_quarter · Q1
Educate policymakers about advanced wound care technologies and patient access to skin substitutes for wound care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INFINITA CITY INC. via INVARIANT LLC
2026 · first_quarter · Q1
Monitor policy issues related to high-fidelity Real-World Evidence to accelerate drug development.
SAGE via INVARIANT LLC
2026 · first_quarter · Q1
Monitor policies to support innovation in the senior living and long-term care sector. Monitor issues related to the use of artificial intelligence in health care.
ABRIDGE AI INC. via INVARIANT LLC
2026 · first_quarter · Q1
Educate policymakers on the role of AI-enabled clinical documentation technology in health care delivery and in reducing clinician burnout.
Promote policies that enhance the role of AI-enabled clinical documentation technology in health care delivery.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
VSP via INVARIANT LLC
2026 · first_quarter · Q1
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Educate policymakers on the importance of effective glycemic management practices.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE, Veterans Affairs, Dept of (VA)
DSM-FIRMENICH via INVARIANT LLC
2026 · first_quarter · Q1
Educate policymakers on the importance of biomanufacturing and protecting the domestic manufacturing capacity of vitamins.
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
CIGNA CORPORATION via INVARIANT LLC
2026 · first_quarter · Q1
Monitor pharmacy issues related to TRICARE.
Educate lawmakers on issues related to pharmacy benefit managers and drug pricing; proposals impacting employer-sponsored insurance; and proposals related to telehealth.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INFINITA CITY INC. via INVARIANT LLC
2026 · first_quarter · RR
High-fidelity real-world evidence to accelerate drug development.
ABRIDGE AI INC. via INVARIANT LLC
2026 · first_quarter · RR
AI-enabled clinical documentation technologies in health care delivery.
AI-enabled clinical documentation technologies in health care delivery.
SAGE via INVARIANT LLC
2026 · first_quarter · RR
Innovation in the senior living and long-term care sector and the use of artificial intelligence in healthcare.
VSP via INVARIANT LLC
2025 · fourth_quarter · Q4
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CIGNA CORPORATION via INVARIANT LLC
2025 · fourth_quarter · Q4
Monitor pharmacy issues related to TRICARE.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE